Ethosuximide Solution
Product Images NDC 0121-0670

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ethosuximide (NDC 0121-0670). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pai Holdings, Llc Dba Pai Pharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Ethosuximide 01)

FDA Label Image

Principal Display Panel (473 mL Bottle Label)

Principal Display Panel (473 mL Bottle Label)
Ethosuximide is an oral solution medication used for the treatment of seizures related to epilepsy. It comes in a 473 mL bottle with a child-resistant closure and must be kept in a tight, light-resistant container at controlled room temperature. Each 5 mL of the medication contains 250 mg of Ethosuximide. It is important to dispense the medication guide to each patient and keep it away from children. For more information, refer to the accompanying literature.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.